Inventor · disambiguated record
Yong-Chen Lu
Also filed as: LU YONG · LU YONG-CHEN
13 granted patents·11 pending applications·35 citations·filing 2014–2025
88Inventor score
Files withUS HEALTH17CLEVELAND CLINIC FOUND2THE UNITED STATES OF AMERICA A REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVI1THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES1THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC1
Top patents by PatentIndex Score
24 records- 0196US11208456B2Anti-KRAS-G12D T cell receptorsUS HEALTH·Filed 2020·Granted Dec 28, 2021·8 cites·36 claims
- 0294US10611816B2Anti-KRAS-G12D T cell receptorsUS HEALTH·Filed 2017·Granted Apr 7, 2020·9 cites·17 claims
- 0392US9694033B2IL-9 secreting CD8+ Tc9 cells and methods of treating cancerCLEVELAND CLINIC FOUND·Filed 2015·Granted Jul 4, 2017·12 cites·11 claims
- 0488US12391742B2Anti-KRAS-G12D T cell receptorsUS HEALTH·Filed 2024·Granted Aug 19, 2025·0 cites·20 claims
- 0588US11897933B2Anti-KRAS-G12D T cell receptorsUS HEALTH·Filed 2021·Granted Feb 13, 2024·1 cites·35 claims
- 0688US2025340611A1Anti-kras-g12d t cell receptorsTHE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2025·Application pending·0 cites
- 0784US10556940B2T cell receptors recognizing HLA-Cw8 restricted mutated KRASUS HEALTH·Filed 2016·Granted Feb 11, 2020·4 cites·20 claims
- 0881US2025059508A1Methods of isolating t cells having antigenic specificity for a cancer-specific mutationUS HEALTH·Filed 2024·Application pending·0 cites
- 0980US2023406904A1T cell receptors recognizing hla-cw8 restricted mutated krasUS HEALTH·Filed 2023·Application pending·0 cites
- 1078US11840561B2Anti-KRAS-G12D T cell receptorsUS HEALTH·Filed 2021·Granted Dec 12, 2023·0 cites·26 claims
- 1174US11939365B2T cell receptors recognizing mutated P53US HEALTH·Filed 2018·Granted Mar 26, 2024·1 cites·19 claims
- 1274US2024124935A1Methods of isolating neoantigen-specific t cell receptor sequencesUS HEALTH·Filed 2023·Application pending·0 cites
- 1371US12171818B2Methods of isolating T cells having antigenic specificity for a cancer-specific mutationUS HEALTH·Filed 2021·Granted Dec 24, 2024·0 cites·20 claims
- 1471US10973894B2Methods of isolating T cells having antigenic specificity for a cancer-specific mutationUS HEALTH·Filed 2014·Granted Apr 13, 2021·0 cites·15 claims
- 1571US2024270814A1T cell receptors recognizing mutated p53THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2024·Application pending·0 cites
- 1670US2023203124A1Methods of isolating t cell receptors having antigenic specificity for a cancer-specific mutationTHE UNITED STATES OF AMERICA A REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVI·Filed 2022·Application pending·0 cites
- 1770US2023026180A1Hla class i-restricted t cell receptors against mutated rasUS HEALTH·Filed 2022·Application pending·0 cites
- 1869US11667692B2T cell receptors recognizing HLA-CW8 restricted mutated KRASUS HEALTH·Filed 2020·Granted Jun 6, 2023·0 cites·20 claims
- 1965US11466071B2HLA class I-restricted t cell receptors against mutated RASUS HEALTH·Filed 2018·Granted Oct 11, 2022·0 cites·44 claims
- 2062US2025170120A1Allosteric sting modulators and methods of useUNIV TEXAS·Filed 2023·Application pending·0 cites
- 2161US11898207B2Methods of isolating neoantigen-specific T cell receptor sequencesUS HEALTH·Filed 2018·Granted Feb 13, 2024·0 cites·10 claims
- 2253US2017218042A1Methods of isolating t cell receptors having antigenic specificity for a cancer-specific mutationUS HEALTH·Filed 2014·Application pending·0 cites
- 2351US2017266233A1IL-9 SECRETING CD8+ Tc9 CELLS AND METHOD OF TREATING CANCERCLEVELAND CLINIC FOUND·Filed 2017·Application pending·0 cites
- 2449US2021113617A1Methods and compositions for th9 cell mediated cancer treatmentUNIV WAKE FOREST HEALTH SCIENCES·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yong-Chen Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →